Suppr超能文献

结直肠癌肝转移治疗的最新进展

Recent advances in the treatment of colorectal liver metastases.

作者信息

Jain Sundeep, Sacchi M, Vrachnos P, Lygidakis N J, Andriopoulou E

机构信息

Department of Surgical Oncology, Henry Dunant Hospital, Athens, Greece.

出版信息

Hepatogastroenterology. 2005 Sep-Oct;52(65):1567-84.

Abstract

Liver metastases are the major cause of death coloroctal resection for cancer. Colorectal liver metastases are unique because of the potential for cure. Presently surgical resection is the gold standard of treatment. Complete R0 resection gives 5-year survival of up to 24-44%. Over the years there have been extensive efforts in devising new modalities of treatment for this disease. These include methods to increase the resectability such as portal after vein emolization & two-stage surgery, py with newer drugs and methods such chronotherapy & hepatic artery infusion chemotherapy, newer methods of radiotherapy, local ablative therapies such as cryoablation, radiofequency ablation, microwave ablation & laser interstitial thermal therapy, and biological therapy. Biological therapy is largely investigational, but holds great promise for the future.

摘要

肝转移是结直肠癌切除术后死亡的主要原因。结直肠癌肝转移具有独特性,因为存在治愈的可能性。目前,手术切除是治疗的金标准。R0 完全切除可使 5 年生存率高达 24% - 44%。多年来,人们一直在广泛努力设计针对这种疾病的新治疗方式。这些包括提高可切除性的方法,如门静脉栓塞和两阶段手术,联合使用更新的药物和时辰疗法、肝动脉灌注化疗等方法,更新的放射治疗方法,局部消融疗法,如冷冻消融、射频消融、微波消融和激光间质热疗,以及生物治疗。生物治疗在很大程度上仍处于研究阶段,但对未来有很大的前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验